PULSE REDUCTION IN MANAGEMENT OF HYPERTROPHIC CARDIOMYOPATHY (TWO CLINICAL CASES)

Abstract

Two clinical cases presented, of the patients with hypertrophic cardiomyopathy and individualized pulse reduction therapy approach. Patients were prescribed consequently bisoprolol and ivabradine (Coraxan®, “Les Laboratoires Servier”, France) with comparative efficacy assessment by a complex investigation that included EchoCG, exercise tests, 24-hour monitoring of ECG and BP.

Keywords

• hypertrophic cardiomyopathy
• bisoprolol
• ivabradine
• stress echocardiography